XNAS
ROIV
Market cap27bUSD
Jul 09, Last price
36.81USD
1D
2.00%
1Q
30.49%
IPO
253.94%
Name
Roivant Sciences Ltd
Chart & Performance
P/E
—
P/S
3,205.37
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.26%
Rev. gr., 5y
-19.07%
Revenues
8m
-71.57%
Net income
-300m
L+74.30%
CFO
-750m
L-10.61%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2020 and headquartered in Menlo Park, California, Montes Archimedes Acquisition Corp. is dedicated to completing business combinations. These combinations encompass a variety of structures, such as mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations, with other enterprises.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||